An Open Label, Single-Dose, Single Period Study Designed to Assess the Mass Balance Recovery, Metabolite Profile and Metabolite Identification of [14C]-A4250 in Healthy Male Subjects

Trial Profile

An Open Label, Single-Dose, Single Period Study Designed to Assess the Mass Balance Recovery, Metabolite Profile and Metabolite Identification of [14C]-A4250 in Healthy Male Subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 20 Mar 2017

At a glance

  • Drugs A 4250 (Primary)
  • Indications Alagille syndrome; Intrahepatic cholestasis; Liver disorders; Primary biliary cirrhosis
  • Focus Pharmacokinetics
  • Sponsors Albireo AB
  • Most Recent Events

    • 20 Mar 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top